Are national cancer control indicators for patient experiences being met in regional and remote Australia? A cross-sectional study of cancer survivors who travelled for treatment by Dunn, Jeff et al.
Edith Cowan University 
Research Online 
ECU Publications Post 2013 
2021 
Are national cancer control indicators for patient experiences 
being met in regional and remote Australia? A cross-sectional 
study of cancer survivors who travelled for treatment 
Jeff Dunn 
Belinda Goodwin 
Joanne F. Aitken 
Sonja March 
Fiona Crawford-Williams 
See next page for additional authors 
Follow this and additional works at: https://ro.ecu.edu.au/ecuworkspost2013 
 Part of the Public Health Commons 
10.1136/bmjopen-2020-042507 
Dunn, J., Goodwin, B., Aitken, J. F., March, S., Crawford-Williams, F., Ireland, M., ... Chambers, S. K. (2021). Are 
national cancer control indicators for patient experiences being met in regional and remote Australia? A cross-
sectional study of cancer survivors who travelled for treatment. BMJ Open, 11(2), article e042507. https://doi.org/
10.1136/bmjopen-2020-042507 
This Journal Article is posted at Research Online. 
https://ro.ecu.edu.au/ecuworkspost2013/10066 
Authors 
Jeff Dunn, Belinda Goodwin, Joanne F. Aitken, Sonja March, Fiona Crawford-Williams, Michael Ireland, 
Nicholas Ralph, Leah Zajdlewicz, Arlen Rowe, and Suzanne K. Chambers 
This journal article is available at Research Online: https://ro.ecu.edu.au/ecuworkspost2013/10066 
1Dunn J, et al. BMJ Open 2021;11:e042507. doi:10.1136/bmjopen-2020-042507
Open access 
Are National Cancer Control Indicators 
for patient experiences being met in 
regional and remote Australia? A cross- 
sectional study of cancer survivors who 
travelled for treatment
Jeff Dunn,1,2,3,4,5 Belinda Goodwin   ,1,2 Joanne F Aitken,1,2,3,6 Sonja March,2,7 
Fiona Crawford- Williams,2 Michael Ireland,2,7 Nicholas Ralph,2,5 Leah Zajdlewicz,1 
Arlen Rowe,2,7 Suzanne K Chambers2,3,5,8
To cite: Dunn J, Goodwin B, 
Aitken JF, et al.  Are National 
Cancer Control Indicators for 
patient experiences being met in 
regional and remote Australia? 
A cross- sectional study of 
cancer survivors who travelled 
for treatment. BMJ Open 
2021;11:e042507. doi:10.1136/
bmjopen-2020-042507
 ► Prepublication history and 
supplemental material for this 
paper is available online. To 
view these files, please visit 
the journal online (http:// dx. doi. 
org/ 10. 1136/ bmjopen- 2020- 
042507).
Received 07 July 2020
Revised 18 January 2021
Accepted 03 February 2021
For numbered affiliations see 
end of article.
Correspondence to
Dr Belinda Goodwin;  
 belindagoodwin@ cancerqld. 
org. au
Original research
© Author(s) (or their 
employer(s)) 2021. Re- use 
permitted under CC BY- NC. No 
commercial re- use. See rights 
and permissions. Published by 
BMJ.
ABSTRACT
Objective To examine the health services experience of 
patients with cancer from regional and remote Australia 
using the Australian National Cancer Control Indicators (NCCI) 
guidelines as an assessment framework.
Design Cross- sectional.
Setting Queensland non- for- profit cancer accommodation 
lodges.
Participants Participants were patients with cancer who 
travelled for treatment from rural and remote Queensland to 
major urban centres (n=518; age mean=64.6, SD=11.18).
Outcome measures Assessments included NCCI patient 
indicators, quality of life (QoL), psychological distress and 
unmet supportive care needs.
Results The frequency at which NCCI indicators were met 
ranged from 37.5% for receiving an assessment and care 
plan to 97.3% for understanding explanations about diagnosis. 
Geographical considerations did not impact patient experience, 
whereas middle school educated participants were more 
likely than those with senior- level education or higher to 
receive an assessment and care plan (OR=1.90, 95% CI 1.23 
to 2.91) and to report having their views on treatment taken 
into account (OR=2.22, 95% CI 1.49 to 3.33). Patients with 
breast or prostate cancer reported better communication and 
patient involvement and information and services provision 
(r=p<0.001) compared with those with skin and head and 
neck cancer. When compared with information and service 
provision, communication and patient involvement showed 
stronger positive associations with QoL (z=2.03, p=0.042), 
psychosocial (z=2.05, p=0.040) and patient care (z=2.00, 
p=0.046) outcomes.
Conclusion The patient care experience varies across the 
NCCI indicators by sociodemographic and clinical factors that 
likely reflect healthcare system biases. Perceptions about 
communication and involvement appear most critical for 
optimal outcomes and should be a priority action area for 
cancer control.
INTRODUCTION
In Australia, as in other high- income countries, 
cancer care delivery systems continue to be 
tested by increasing cancer prevalence due to 
an ageing population and increasing survival.1 
Compounding this, widening socioeconomic 
and geographical inequities in cancer outcomes,2 
increasing healthcare costs and workforce short-
ages3 4 are all exacerbated by rapidly expanding 
and complex cancer diagnostic and treatment 
options.5 In response, national societies and 
cancer control agencies globally have devel-
oped frameworks and guidelines for quality care 
cancer services that typically include characteris-
tics such as being person- centred and tailored, 
evidence- based, coordinated, multidisciplinary, 
quality assured and accountable.6–9 While 
many of these guidelines focus on treatment, 
supportive and psychosocial care is also a central 
feature. For example, the first (of eight) recom-
mendations from the Institute of Medicine 2013 
report centres on patients and families receiving 
Strengths and limitations of this study
 ► This is the first study to quantitatively measure and 
test the National Cancer Control Indicators for pa-
tient experience.
 ► Findings provide important insight into the patient 
experience for a regional and remote population 
who are at risk of fragmented or poorly coordinated 
care.
 ► This large representative sample was recruited from 
a state- wide jurisdiction and so likely represents the 
actual experience of patients from regional and re-
mote Australia.
 ► This study was cross- sectional; therefore, causality 
cannot be assumed.
 ► This study was aimed at gaining an insight into the 
experiences of regional and remote patients with 
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understandable information about all aspects of their cancer 
care.8 The Australian government’s guides to best- practice 
cancer care, the Optimal Cancer Care Pathways, list access to 
supportive care, including survivorship, as a key theme across 
all steps of the care pathway.7 Similarly, risk stratified pathways 
of cancer care in the UK emphasise assessing and supporting 
holistic patient needs, including those that are psychosocial 
and spiritual. While such frameworks are important, the 
question arises as to how cancer services might best evaluate 
the extent to which cancer care is meeting these recommen-
dations, where gaps most exist and, crucially who is more 
vulnerable to underservicing.
A number of groups have developed indicators to reflect 
the extent to which optimal care is being delivered in terms of 
information, communication, education and care coordina-
tion during diagnosis and treatment.10 11 Thus far, this been 
for quality assurance purposes within administering jurisdic-
tions, with findings not generally presented within the peer- 
reviewed literature. A set of items was recently developed by 
Cancer Australia for monitoring patients with cancer expe-
riences at the national level. The National Cancer Control 
Indicators (NCCI) patient experiences items are based on 
the National Health Service (NHS) England Cancer Patient 
Experience Survey12 and reflect the receipt and under-
standing of information about diagnosis and side effects of 
treatment, as well as patient involvement in care and decision 
making, and the provision of care coordination tools and 
services. To date, results from the Australian NCCI indicators 
for patient experience have not been reported.
It is especially important to consider the quality of the 
patient experience for people who live in geographically 
remote locations. People with cancer living in remote loca-
tions incur the additional burden of having to travel long 
distances to attend specialist treatment facilities that are 
not available in sparsely populated and geographically 
remote areas of the country.13 Patients with cancer who live 
outside of major cities in Australia are known to experience 
poorer cancer outcomes14 15 and report poor physical and 
mental health,16 17 lower quality of life (QoL)18 19 and unmet 
supportive care needs18 20 21 compared with their urban 
counterparts.
Accordingly, the present study applied the NCCI guide-
lines as a framework to examine the health services experi-
ence of patients with cancer and their families from regional 
and remote Australia experiencing geographical disloca-
tion while obtaining cancer treatment. In doing so, (1) the 
construct validity of the NCCI guidelines was examined; (2) 
the extent to which these guidelines are currently being met 
was tested; (3) sociodemographic predictors of underser-
vicing were explored; and (4) how psychosocial outcomes, 
unmet supportive care needs, satisfaction with healthcare 
were related to underservice were described.
METHODS
Patient and public involvement statement
Patient and public involvement in the design and conduct 
of the study was sought from community members, 
research volunteers and pilot study participants. Several 
community members, including cancer survivors living in 
rural areas, reviewed interview and questionnaire items 
providing feedback on the clarity, formatting and time to 
complete. The research volunteers tested and evaluated 
materials and protocols, while patients provided written 
and verbal feedback to researchers regarding clarity, 
burden and relevance associated with completing study 
materials. Minor refinements to the study materials were 
made to increase clarity and ease of delivery based on this 
feedback.
Participants
Participants (n=518) were patients with cancer from 
regional and remote Queensland staying at six Cancer 
Council Queensland (CCQ) lodges. CCQ is a not for profit 
organisation offering a range of services to those affected 
by cancer, one of those being the accommodation lodges 
which aim to limit out of pocket expenses for patients. 
People who are diagnosed with cancer, who are required 
to travel for their treatment, may receive a referral to stay 
at one of the CCQ lodges from their healthcare team. 
Accommodation costs are determined in conjunction 
with the patient’s eligibility for the Queensland govern-
ment’s Patient Travel Subsidy Scheme, which is designed 
to assist in the cost of travel to the nearest specialist 
medical service that is more than 50 km from the patients 
nearest hospital. Figure 1 depicts participant recruitment 
flow. Eligibility criteria were 18 years or older, ability to 
read and understand English, and staying at a CCQ lodge 
for cancer treatment. A total of 14 015 of 1811 eligible 
CCQ lodge guests staying between 11 September 2017 
and 1 February 2020 were provided with an invitation 
pack containing study details, consent forms and a ques-
tionnaire. Three hundred and ninety- six eligible guests 
were not approached as contact details were not provided 
or accurate.
Invitation packs were distributed on arrival by lodge 
staff or, if this was not possible (eg, after hours check- in), 
were sent via mail to their home address. Patients were 
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contacted by phone 1 week after pack distribution, offered 
further details and invited to participate. Assessments 
included a Self- Administered Questionnaire (SAQ) and 
face- to- face (or telephone) interview at baseline, followed 
by SAQs at 3 and 12 months and annually thereafter.
Of the eligible patients who received an invitation pack 
(n=1415), 645 (45.2%) consented to participate, 395 
(28.1%) actively refused, and 375 (26.7%) did not return 
a consent form and could not be recontacted. This report 
focusses on data collected at baseline for a sample of 
518 consenting participants who had a cancer diagnosis 
and completed both the questionnaire and interview 
components of the study. Based on the available names 
and addresses of non- respondents, it could be estimated 
that responders and non- responders did not differ signifi-
cantly according to gender, remoteness or socioeconomic 
status.
Materials and measures
Questionnaires assessed demographic and patient char-
acteristics, patient experiences according to the NCCI, 
psychological distress and cognitive adjustment, satisfac-
tion with healthcare, QoL and supportive care needs. 
Structured interviews assessed diagnostic and treatment 
pathways.
Demographics and patient characteristics
Site of current cancer, gender, age, country of birth, 
highest level of education and household income were 
reported by each participant. Participant’s residential 
street address at baseline was geocoded and mapped to 
the 2011 SA2 boundaries using MapMarker Australia 
V.15.16.0.21 and MapInfo Pro V.5.0 and classified by 
Remoteness Area22 and Socioeconomic Index for Areas 
(SEIFA).23 The most recently diagnosed primary cancer 
site was obtained via self- report and verified against the 
population- based Queensland Cancer Register (QCR). 
Self- report data were relied on where diagnosis could not 
be verified by the QCR (n=39), for example, if the patient 
had non- melanoma skin cancer (which is not routinely 
notified to registries in Australia) or the patient’s diag-
nosis had not yet been notified to the QCR.
NCCI: patient experience
Eight items derived from the NHS England Cancer Patient 
Experience Survey10 were adapted by Cancer Australia12 
as measures of NCCI of patients with cancer experi-
ences. The items captured four key elements, including 
(1) patient information, communication and education 
during diagnosis; (2) patient information, communica-
tion and education during treatment; (3) patient coordi-
nation and integration of care, continuity and transition; 
and (4) respect for patient preference. Response scales 
for each item vary, including three- category (eg, yes, no, 
I don’t know/remember) and four- category (eg, yes, yes 
to some extent, no, I don’t know/remember) response 
options. Responses to each NCCI item were collapsed 
into a yes/no binary response with those responding with 
‘I don’t know’ or ‘I don’t remember’ coded as missing. 
Full- item wording, response categories and method for 
collapsing responses are available in as supplementary 
material (online supplemental file 1).
As the NCCI items have not been validated for use in 
research, an exploratory factor analysis was conducted 
for the current sample. One- factor to four- factor solu-
tions were extracted sequentially using Mplus V.8 soft-
ware.24 The decision on the number of factors to retain 
was driven by (1) the overall and comparative model fit 
(determined by χ2 and Δχ2 and their corresponding p 
values), (2) balancing the trade- off between explanatory 
power and parsimony (determined by the Bayesian and 
the Akaike information criteria), and (3) an interpretable 
pattern of strong and non- cross- loading factor loadings.
For the one- factor to three- factor solutions, overall 
model fit improved as a function of the number of factors 
extracted (see table 1). However, the four- factor solu-
tion yielded a poorer fit than the three- factor solution 
according to both χ2 and information criteria values and 
was not considered a candidate solution. The Bayesian 
information criterion shows that the three- factor solu-
tion exhibited poorer fit compared with the two- factor 
solution once model complexity was accounted for. 
Therefore, the two- factor solution represented the best 
trade- off of explanatory power and parsimony. Finally, 
the two- factor solution also yielded a simple structure 
in the pattern of item loadings. Each NCCI item loaded 
cleanly onto one of each of the two factors (see table 2), 
the first reflecting effective communication and patient 
involvement and the second reflecting the provision of 
information or services. A confirmatory factor analytic 
approach was used to calculate factor score variables for 
the communication and patient involvement and provi-
sion of information and services. Factor score variables 
were transformed so that scores ranged from 0 (low) to 
1.68 (high) for the communication and patient involve-
ment factor and 0 (low) to 1.84 (high) for the provision 
of information and services factor.
Psychological distress and adjustment
Stress, anxiety and depression were measured using the 
21- Item Depression, Anxiety and Stress Scale.25 The scale 
Table 1 Comparative fit statistics for one- factor to four- 
factor exploratory factor analysis solutions
One- factor Two- factor Three- factor Four- factor
AIC 3848.70 3784.24 3775.34 3787.09
ΔAIC – 64.46 8.89 −11.74
BIC 3916.70 3881.99 3898.59 3931.59
ΔBIC – 34.71 −16.61 −32.99
χ2 (p) 435.96 
(<0.001)





40.37 (<0.001) (Δχ2 is 
negative)
AIC, Akaike's information criterion; BIC, Bayesian information criterion.
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asks respondents to indicate the degree to which each 
statement applied to them over the past week on a 4- point 
Likert scale ranging from 0=not at all to 3=almost always. 
Scores for each subscale were summed and multiplied by 
2, with higher scores indicating more distress.26 Reliability 
for the anxiety (α=0.67), stress (α=0.87) and depression 
(α=0.90) subscales was adequate to excellent.
Psychological adjustment to a cancer diagnosis was 
assessed using the Constructed Meaning Scale (CMS). The 
eight- item CMS measures a patients’ cognitive response to 
being diagnosed with a life- threatening illness27 on a 4- point 
Likert scale ranging from 1=strongly disagree to 4=strongly 
agree. Scores on the CMS reflect ability to construct a posi-
tive outlook regarding the effect that cancer has or will have 
on their future, their relationships and their sense of self. 
Internal consistency in the current study was good (α=0.77).
Satisfaction with healthcare
Nine items were created by the researchers to assess 
patients’ satisfaction with their healthcare in terms of the 
referral process, speed of diagnosis, speed of test results, 
the hospital where they were treated and the doctors and 
nurses, the emotional and physical support they receive 
in hospital and finally, and their medical care overall. 
Degree of satisfaction with each item was reported on 
a 5- point Likert scale ranging from 1=very dissatisfied to 
5=very satisfied. Data and participant feedback from the 
pilot phase were examined to ensure items were clear 
and relevant, and excellent internal consistency for the 
measure was evident (α=0.92). Items were averaged to 
create a mean score.
Quality of life
Multidimensional QoL was measured using the 35- item 
Assessment of Quality of Life 8 Dimension instrument 
(AQoL- 8D).28 Participants responded on a 5- point 
Likert scale based on aspects of QoL during the past 
week. Responses are coded so that lower scores reflect 
poorer QoL on two psychometrically derived dimensions 
reflecting physical and psychological well- being. Internal 
reliability was evident for physical (α=0.64) and psycho-
logical (α=0.92) dimensions in the current study.
Supportive care needs
Unmet need was measured using the Supportive Care 
Needs Survey Short Form-34.29 The scale assesses patient 
need for support across five domains, including physical 
and daily living, psychological, health systems and infor-
mation, patient care and support and sexuality with a 
single item regarding financial needs. Responses were 
coded: 0 (no need/not applicable/need satisfied), 1 (low need), 
2 (moderate need) or 3 (high need), and means were calcu-
lated, resulting in six continuous variables reflecting the 
degree of need in each domain. Subscales showed excel-
lent internal reliability (physical and daily living needs, 
α=0.86; psychological needs, α=0.94; health system and 
information needs, α=0.95; patient care and support 
needs, α=0.88; and sexuality needs, α=0.87).
Analysis
Data analyses were carried out in SPSS V.26.30 Frequencies 
and percentages were calculated for patient responses to 
each NCCI item. Demographics and area- level character-
istic differences in the likelihood of reporting yes to an 
NCCI item were examined using χ2 statistics. A family- 
wise error rate adjustment was applied to constrain the 
chance of type 1 errors to 5%. One- way analyses of vari-
ance were used to identify group differences in NCCI 
factor scores and psychosocial outcomes; Pearson’s point 
biserial correlations assessed whether age was associ-
ated with NCCI items and factors. Where group differ-
ences were significant, post hoc contrasts were applied to 
compare each category against others. ORs and 95% CIs 
were reported for contrasts involving NCCI items. Asso-
ciations between factor scores and health/psychosocial 
variables were assessed using a series of correlations with 
coefficients graphed and compared using Fisher’s z- test. 









Do you think your views were 
taken into account when 
the team of doctors and 
nurses caring for you were 
discussing which treatment 
you should have?
0.884* 0.005
Were you involved as much 
as you wanted to be in 
decisions about your care 
and treatment?
0.925* −0.063
Were the possible side 
effects of treatment(s) 
explained in a way you could 
understand?
0.507* 0.249*
When you were told you had 
cancer, did you understand 
the explanation of what was 
wrong with you?
0.633* 0.059
Have you been offered a 
written assessment and care 
plan?
0.185 0.579*
When you were told you 
had cancer, were you given 
written information about the 
type of cancer you had?
0.075 0.579*
Before you started your 
treatment, were you given 
written information about the 
side effects of treatment(s)?
0.002 0.719*
Were you given the name of a 
clinical nurse specialist who 
would support you through 
your treatment?
−0.001 0.736*
Bold indicates the factor on which item loaded most strongly.
*Geomin rotated loadings significant at 5% level.
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Participant ages ranged from 26 to 93 (mean (M)=64.6, 
SD=11.18), and 47.3% of participants identified as 
female and 52.7% as male. Most participants were born 
in Australia (80.5%), with the remainder born in the UK 
(9.9%), New Zealand (4.7%) and other countries (4.9%). 
Most participants reported low income, with 64.8% 
reporting a household income under $50 000 a year 
(ie, the median yearly gross income in Australia). Most 
patients were not fully covered by private health insur-
ance (81.5%), and the majority lived in inner (44.0%) 
or outer (42.5%) regional areas marked by high levels of 
socioeconomic disadvantage (ie, 66.5% were in the lowest 
socioeconomic quintiles). The most common primary 
cancers were those of the breast (19.3%), head and neck 
(14.3%), and skin (12.6%; see table 3A). References to 
population statistics available through the Queensland 
Cancer Registry, the current sample was representative 
of the non- metropolitan Queensland cancer population 
in terms of gender, age and country of birth. However, 
patients with skin cancer were under- represented (24.5% 
in population) and patients with head and neck cancer 
were over- represented (5.8% in population). At the 
time of data collection, time since diagnosis for each 
participant ranged between and 33.7 years and 1 day 
(Median=211 days), with 64% of participants diagnosed 
within the previous 12 months.
Communication and patient involvement
Participants reported that their views were taken into 
account when their team of doctors and nurses were 
discussing their treatment 59.5% of the time (table 3A). 
Those with middle school education or lower were twice 
as likely to report having their views taken into account 
in treatment decisions (OR=2.22, 95% CI% 1.49 to 3.33) 
compared with those with senior high school or trade- 
level/tertiary- level education. Older patients were slightly 
more likely to report that their views were taken into 
account by doctors and nurses when deciding on treat-
ment (r=0.11, p=0.02). Similarly, 60.8% of participants 
felt they were involved in decisions about their care and 
treatment as much as they would have liked; however, this 
did not vary according to individual characteristics.
Most participants reported understanding the explana-
tion of ‘what was wrong with them’ on diagnosis (97.3%), 
and this did not differ significantly according to individual 
characteristics. More than half of the patients (66.8%) 
reported that the possible side effects of their treatment 
were explained to them in a way they could understand. 
Those with middle school education or lower were 1.5 
times more likely to report having side effects explained 
to them in a way that they understood compared with 
those with trade- level/tertiary- level education (OR=1.50, 
95% CI 1.14 to 1.96), and those with senior level educa-
tion were less likely to report this compared with those 
with trade- level/tertiary- level education (OR=0.65, 95% 
CI 0.46 to 0.90).
Group differences were evident in participants’ scores 
on the communication and patient involvement factor 
with patients possessing middle school- level educa-
tion (M=1.23, SD=0.42) reporting higher scores than 
those with trade- level/tertiary- level education (M=1.08, 
SD=0.42; t (509)=42.75, p<0.001, d=0.36) or those 
with senior school- level education (M=1.05, SD=0.42; 
t (509)=21.88, p<0.001, d=0.43). When compared with 
all other cancer types, patients with breast (M=1.23, 
SD=0.43; t (512)=28.75, p<0.001, d=0.28) and pros-
tate (M=1.20, SD=0.41; t (512)=22.40, p<0.001, d=0.17) 
cancers reported higher scores on the communication 
and patient involvement factor, while those with skin 
(M=1.05, SD=0.46; t (512)=19.75, p<0.001, d=0.22) and 
head and neck (M=1.14, SD=0.42; t (512)=22.83, p<0.001, 
d=0.01) cancers reported lower scores than those with 
other cancer types.
Provision of information and services
Sixty- four per cent of participants were given written 
information about the type of cancer they had. Women 
were 1.69 (95% CI 1.16 to 2.46) times as likely to report 
receiving this information when compared with men. 
Patients with breast cancer were 2.41 (95% CI 1.39 to 
4.42) times more likely, and those with skin cancer were 
0.49 (95% CI 0.28 to 1.18) times as likely to receive written 
information about the type of cancer they had compared 
with those with other cancers. The majority of patients 
reported being given written information about the side 
effects of treatment (84.8%) with those with skin cancer 
less likely to receive this information compared with those 
with other cancer types 0.33 (95% CI 0.17 to 0.65).
Only 37.5% of participants reported receiving a written 
assessment and care plan. Those with middle school 
education or lower were almost two times more likely to 
report receiving an assessment and care plan (OR=1.90, 
95% CI 1.23 to 2.91) compared with those with senior 
high school or trade- level/tertiary- level education. Over 
two- thirds of patients reported being given the name of 
a clinical nurse specialist to support them through treat-
ment (68.9%); however, patients with breast cancer were 
8.07 (95% CI 3.55 to 18.37) times more likely, and patients 
with prostate cancer were 2.77 (95% CI 1.36 to 5.68) 
times more likely to be offered this service compared with 
participants with other types of cancer.
Those with middle school- level education or lower 
(M=1.27, SD=0.48) reported higher scores on the provi-
sion of service and information factor than those with 
trade- level/tertiary- level education (M=1.12, SD=0.47; 
t (509)=39.71, p<0.001, d=0.32) or those with senior 
school- level education (M=1.07, SD=0.46; t (509)=20.28, 
p<0.001, d=0.42). When compared with all other 
cancer types, patients with breast (M=1.36, SD=0.39; 
t (99)=34.47, p<0.001, d=0.54) or prostate (M=1.25, 
copyright.
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SD=0.45; t (63)=22.42, p<0.001, d=0.19) cancer reported 
higher scores on the provision of information and 
services factor, while those with skin (M=0.97, SD=0.54; t 
(64)=14.52, p≤0.001, d=0.46) or head and neck (M=1.16, 
SD=0.48; t (73)=20.73, p<0.001, d=0.03) cancer reported 
lower scores than those with other cancer types. Area- 
level characteristics (ie, remoteness or SEIFA) were 
not significantly associated with single items or factor 
scores reflecting provision of information and services 
(see table 3B). Mean levels of physical QoL (F(4)=5.94, 
p<0.001), anxiety (F(4)=3.42, p=0.009), physical and 
daily living (F(4)=5.02, p<0.001), sexuality (F(4)=3.34, 
p=0.010) and supportive care needs were significant 
different across cancer types. Post hoc comparisons with 
a Bonferroni adjustment showed that breast cancer survi-
vors (M=4.48, SD=4.10) reported significantly lower levels 
of anxiety than those in the ‘other’ cancer group (M=6.63, 
SD=5.94; p=0.015), and those with prostate cancer 
(M=0.50, SD=0.68) and breast cancer (M=0.59, SD=0.68) 
reported lower physical and daily living supportive care 
needs than those in the ‘other’ cancer group (M=0.89, 
SD=0.82; p=0.004 and p=0.012, respectively). Those 
with prostate cancer (M=0.64, SD=0.92) also reported 
significantly higher sexuality supportive care needs than 
those with skin (M=0.29, SD=0.60.), p=0.039) or head 
and neck cancer (M=0.28, SD=0.61; p=0.020), and those 
with breast (M=75.73, SD=10.25) and prostate (M=70.88, 
SD=10.81) cancers report significantly higher physical 
QoL compared with those in the ‘other’ cancer group 
(M=70.88, SD=10.81; both p<0.001).
Associations between NCCI factor scores and health and 
psychosocial variables
Both communication and patient involvement and provi-
sion of information and services factors shared significant 
positive associations with QoL, satisfaction with health-
care and constructed meaning (see figure 2). They were 
also both associated with lower supportive care needs in 
most cases, the strongest associations being with health 
Figure 2 Visual comparison of the correlation coefficients 
between each health/psychosocial variable and each factor. 
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system and information needs. The communication and 
patient involvement factor was moderately associated 
with greater psychosocial QoL (r=0.30, p<0.001) and 
satisfaction with healthcare (r=0.29, p<0.001) as well as 
lower levels of unmet ‘health systems and information’ 
(r=−0.39, p<0.001) and ‘patient care’ (r=0.35, p<0.001) 
needs and lower cancer threat appraisal (r=0.31, p<0.001). 
The provision of information and services factor had a 
weaker pattern of associations though still moderately 
predicted lower levels of unmet ‘health systems and infor-
mation’ (r=−0.32, p<0.001) and ‘patient care’ (r=−0.23, 
p<0.001) needs, as well as greater satisfaction with health-
care (r=0.23, p<0.001). The communication and patient 
involvement factor shared significantly stronger associ-
ations with higher psychosocial QoL (z=2.03, p=0.042) 
and lower levels of unmet need in terms of psychoso-
cial support (z=2.05, p=0.040) and patient care (z=2.00, 
p=0.046). Communication and patient involvement was 
associated with lower stress and anxiety, while provision of 
information and services was not (see figure 2).
Area- level characteristics (ie, remoteness or SEIFA) 
were not significantly associated with single items or 
scores on either NCCI factor (see table 3B).
DISCUSSION
The goal of delivering equitable patient- centred cancer 
care is a corner stone of cancer control plans and care 
guidelines.6 7 9 12 The present study suggests that the NCCI 
patient experience indicators have validity and potential 
as a tool for monitoring and benchmarking the quality of 
cancer care relating specifically to patient understanding 
and involvement. Importantly, this brief tool discrimi-
nated between different aspects of patient experience for 
those dislocated from their home during treatment and 
identified characteristics associated with a poorer experi-
ence. While it was almost universal for patients to recall 
understanding the explanation of their treatment, and 
most people reported that treatment side effects were 
explained and supported with written information, only 
a minority received a written assessment and care plan. 
Further, patient experience varied by clinical and socio-
demographic characteristics, suggesting that there is 
work to be done on better understanding what influences 
care and how we might intervene.
From a construct perspective, the patient experience 
as measured by the NCCI indicators presented along 
two key dimensions: (1) communication and patient 
involvement and (2) provision of information and 
services. For both dimensions, the strong association with 
health system and information needs provides evidence 
of convergent validity. The closer connection between 
communication and patient involvement and QoL and 
psychosocial outcomes intuitively makes sense, given 
the important role of the interpersonal relationships 
between the healthcare teams and patients, as well as 
the self- efficacy and personal agency that evolves from 
the patient’s involvement in their healthcare.31 These 
associations may be bidirectional. Patients with lower 
psychological distress have a higher capacity to absorb 
information, take part in decision making, benefit from 
communications with healthcare professionals32 33 and 
are subsequently more likely to report satisfaction with 
this element of their care.34 In fact, this may be reflected 
in the current findings that patients with breast cancer 
in this sample reported both lower levels of anxiety and 
better patient experiences compared with those with 
other cancers. Those individuals who are psychologically 
vulnerable or have poorer QoL likely need stepped up 
care to achieve optimal outcomes.35
Despite suggestions that remote living is associated 
with poorer experiences for cancer survivors, area- level 
factors were not associated with NCCI outcomes. Rather, 
differences in patient experiences according to cancer 
were apparent. Notably, patients with breast and pros-
tate cancers were more likely to receive clinical nurse 
support compared with patients with skin and head and 
neck cancers. This may reflect the different resources 
and services available for specific cancers, for example, 
the introduction of the specialist nurse role for patients 
with breast cancer,36 and more recently patients with pros-
tate cancer.37 While a specialist nurse appears to greatly 
enhance patient experience,38 providing this for all 
cancer types is likely a resourcing challenge especially for 
regional and remote health services. Models that incor-
porate telehealth and that span broadly across multiple 
cancer types or chronic disease may be needed.39 Higher 
education appeared to be associated with less commu-
nication and patient involvement and information and 
services. The reasons for this are unclear, but it may be 
that health professionals assume these patients require 
less support or alternatively that people with more educa-
tion have greater expectations in this domain of care.
As the aim of the present study was to provide specific 
insight into the experiences of regional and remote 
patients with cancer, caution should be in applied in 
generalising these findings to urbanised populations. 
Since the survey is cross- sectional we cannot assume 
causality; and the data are self- reported and were not 
able to be verified by observational data or care records. 
However, this large, representative sample was recruited 
from a statewide jurisdiction and so likely represents the 
actual experience of patients from regional and remote 
Australia. Although regional and remote areas tend to 
be marked by higher socio- economic disadvantage in 
Australia,23 the particularly low SES status of this sample 
may be due to recruiting participants through free or low- 
cost accommodation services. Low levels of variance in 
area- level disadvantage in this sample may have impeded 
the detection of significant effects. These alternative 
hypotheses should be the subject of future research with 
samples not in receipt of such services. Although the aim 
of the current research was to assess patient experiences 
using a metric published by a national governing body, it 
is important to note that several valid measures of patient 
experience covering different aspects of patients’ care 
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and support needs exist,10 11 29 and future research will 
benefit from their inclusion.
The present results outline the patient experience for 
a rural and regional population who are at risk of frag-
mented or poorly coordinated care. Patients who report 
better communication with their healthcare team and 
more involvement have better QoL, less stress and anxiety, 
and lower threat. Fulfilling the NCCI indicators connects 
to lower unmet need in health services and information. 
Cancer care services that ensure these indicators are met 
are better placed to provide an optimal cancer experi-
ence and improved patient- reported outcomes.
The NCCI presents as a useful and valid tool for 
assessing the patient experience. The aspect of care that 
appears most crucial is communication and involvement 
with the healthcare team. Strategies to optimise this for 
regional and remote patients need to be a cancer control 
priority.
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